Canada’s Biotech Ecosystem is Thriving: Tailored Genes is Leading the Way
The recent announcement of AstraZeneca’s C$820 million investment in Canada is a testament to the nation’s emergence as a global […]
The recent announcement of AstraZeneca’s C$820 million investment in Canada is a testament to the nation’s emergence as a global […]
Canada is rapidly emerging as a global powerhouse in biomanufacturing, with increased investment in research, training, and infrastructure. With initiatives
Traditional cancer treatments, including chemotherapy and radiation, have long been the standard of care. However, gene therapy presents a new
At Tailored Genes, we believe that every scientific breakthrough starts with a partnership built on trust, precision, and bold ambition.
As global demand for gene therapy manufacturing soars, we’re seeing a growing strain on capacity, timelines, and reliability. Between the